The Cross-Country Comparison Model for Labor Participation (CCC Model for LP) of Persons with Chronic Diseases.
Angelique de Rijk, Karina Carrasco-Negüe, Inge Houkes
PMID 35723804WHAT IT FOUND
A new framework helps compare why employment rates for people with chronic diseases differ between countries.
It looks at laws, professional norms, culture, how care is organized, and labor markets. It offers no evidence that any specific treatment improves work participation.
Key findings
01The model identifies five factors that shape cross-country differences in labor participation for people with chronic diseases: legislation, norms and values, culture, organization of work disability prevention, and labor market characteristics.
02A simple tool called LOLA was developed to help estimate whether a policy or intervention from one country can be transferred to another by checking similarities in legislation, organizations, labor markets, and cultural fit.
03The model is descriptive and sociological, not causal. It helps understand differences but does not prove that changing a specific factor will improve employment outcomes.
STILL TO COME
How it was doneWhat they found
Read the rest of this summary
You get three full summaries a month, free, and we do not ask for a card. Search, the TL;DRs and your library stay unlimited either way.
What it does not show
The literature search was not systematic and did not assess the quality of the studies included. Most evidence came from high-income European countries, limiting its applicability to other regions. The model describes associations and contexts but does not prove cause and effect. The LOLA tool has not been validated for reliability or accuracy in real-world policy transfer.
Declared interests
The text does not report funding sources or conflicts of interest.
The easy way to misread this
Do not use this paper to justify changing your clinical interventions to improve patient employment outcomes. This is a theoretical framework for comparing countries, not a clinical trial or guideline. It does not test any treatment or provide evidence that specific therapies increase labor participation.